Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
Genome Research · 2023-06 · 33 (6) · 923-931
DOI: 10.1101/gr.277585.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, online erschienen am 11.05.2023. Verfasst von Li Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Receptors, KIR. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Killer cell immunoglobulin like receptor (KIR) genes and human leukocyte antigen (HLA) genes play important roles in innate and adaptive immunity. They are highly polymorphic and cannot be genotyped with standard variant calling pipelines. Compared with HLA genes, many KIR genes are similar to each other in sequences and may be absent in the chromosomes. Therefore, although many tools have been developed to genotype HLA genes using common sequencing data, none of them work for KIR genes. Even specialized KIR genotypers could not resolve all the KIR genes. Here we describe T1K, a novel computational method for the efficient and accurate inference of KIR or HLA alleles from RNA-seq, whole-genome sequencing, or whole-exome sequencing data. T1K jointly considers alleles across all genotyped genes, so it can reliably identify present genes and distinguish homologous genes, including the challenging KIR2DL5A / KIR2DL5B genes. This model also benefits HLA genotyping, where T1K achieves high accuracy in benchmarks. Moreover, T1K can call novel single-nucleotide variants and process single-cell data. Applying T1K to tumor single-cell RNA-seq data, we found that KIR2DL4 expression was enriched in tumor-specific CD8 + T cells. T1K may open the opportunity for HLA and KIR genotyping across various sequencing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
- Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA lib3@chop.edu hli@ds.dfci.harvard.edu.
- Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; lib3@chop.edu hli@ds.dfci.harvard.edu.
ORCID-Profile: Heng Li
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Song, L., Bai, G., Liu, X. S., Li, B., & Li, H. (2023). Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. Genome Research, 33(6), 923-931. https://doi.org/10.1101/gr.277585.122
Vancouver
Song L, Bai G, Liu XS, Li B, Li H. Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. Genome Research. 2023;33(6):923-931. doi:10.1101/gr.277585.122
BibTeX
@article{Song2023,
author = {Song, Li and Bai, Gali and Liu, X Shirley and Li, Bo and Li, Heng},
title = {Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data},
journal = {Genome Research},
year = {2023},
volume = {33},
number = {6},
pages = {923--931},
doi = {10.1101/gr.277585.122}
}
EUVIMED